Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms

The 2016 World Health Organization classification introduced a number of genes with somatic mutations and a category for germline predisposition syndromes in myeloid neoplasms. We have designed a comprehensive next-generation sequencing assay to detect somatic mutations, translocations, and germline...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Borahm, Lee, Hyeonah, Jang, Jieun, Kim, Soo-Jeong, Lee, Seung-Tae, Cheong, June-Won, Lyu, Chuhl Joo, Min, Yoo Hong, Choi, Jong Rak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402635/
https://www.ncbi.nlm.nih.gov/pubmed/30840646
http://dx.doi.org/10.1371/journal.pone.0212228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402635/
https://www.ncbi.nlm.nih.gov/pubmed/30840646
http://dx.doi.org/10.1371/journal.pone.0212228

Ejemplares similares